4//SEC Filing
Kunin Audrey 4
Accession 0001437749-22-028031
CIK 0001389545other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:16 PM ET
Size
5.1 KB
Accession
0001437749-22-028031
Insider Transaction Report
Form 4
Kunin Audrey
Chief Product Officer
Transactions
- Sale
Common Stock
2022-11-21$2.10/sh−5,960$12,545→ 0 total(indirect: See footnote)
Footnotes (3)
- [F1]On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.
- [F2]This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001738781
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:16 PM ET
- Size
- 5.1 KB